Endovascular correction of renal artery stenosis of the solitary functioning kidney in a patient with essential thrombocythemia
https://doi.org/10.35754/0234-5730-2024-69-2-260-268
Abstract
Introduction. Renal artery stenosis is a common pathology associated mainly with atherosclerosis of the renal arteries. Essential thrombocythemia (ET) is a rare cause of renal artery stenosis.
Aim: to describe a clinical observation of a patient with ET, complicated by renal artery stenosis of a solitary functioning kidney, successfully corrected endovascularly.
Main findings. A 32-year-old male with ET, complicated by occlusion of the abdominal aorta, left renal artery, with shrinkage of the left kidney, subtotal stenosis of the right renal artery and chronic kidney disease stage 3A, as well as renovascular hypertension, underwent an organ-preserving intervention — endovascular correction of renal artery stenosis (ECRAS). As a result of ECRAS, the prescription of anticoagulant-antiplatelet therapy and specific therapy for ET with interferon, positive effects were observed in the form of improved kidney function, achievement of target blood pressure level, as well as in relation to basic hematological parameters.
About the Authors
D. Yu. Popov
Ural State Medical University
Russian Federation
Russian Federation
Dmitry Yu. Popov, Senior Lecturer, Department of Propaedeutics of Internal Diseases
620028, Ekaterinburg
N. S. Kiselev
Sverdlovsk Regional Clinical Hospital No. 1
Russian Federation
Russian Federation
Nikolay S. Kiselev, Cand. Sci. (Med.), physician of the X-ray endovascular diagnostic and treatment Department
620102, Ekaterinburg
A. G. Stolyar
Sverdlovsk Regional Clinical Hospital No. 1
Russian Federation
Russian Federation
Aleksey G. Stolyar, Dr. Sci. (Med.), Head of the Nephrology Department
620102, Ekaterinburg
References
1. Melikyan A.L., Kovrigina A.M., Subortseva I.N., et al. National clinical guidelines for the diagnosis and treatment of ph-negative myeloproliferative diseases (true polycythemia, essential thrombocythemia, primary myelofibrosis) (2018 edition). Gematologiya i transfuziologiya. 2018; 3(63): 275–315. (In Russian). DOI: 10.25837/HAT.2019.51.88.001.
2. Meier B., Burton J.H. Myeloproliferative Disorders. Hematol Oncol Clin North Am. 2017; 31(6): 1029–44. DOI: 10.1016/j.hoc.2017.08.007.
3. Federal Law № 323-FL “On the Basics of Protecting the Health of Citizens in the Russian Federation”. Article 44, part 1. (In Russian).
4. Ashorobi D., Gohari P. Essential Thrombocytosis (Essential Thrombocythemia, ET). StatPearls Publishing; 2020 Jan. Bookshelf ID: NBK539709. PMID: 30969531.
5. Arber D.A., Orazi A., Hasserjian R., et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016; 127: 2391–405. DOI: 10.1182/blood-2016-03-643544.
6. Tefferi A., Barbui T. Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management. Am J Hematol. 2019; 94: 133–43. DOI: 10.1002/ajh.25303.
7. Tefferi A., Vannucchi A., Barbui T. Essential thrombocythemia treatment algorithm 2018. Blood Cancer J. 2018; 8: 2. DOI: 10.1038/s41408-017-0041-8.
8. Shilov E.M., Smirnov A.V., Kozlovskaya N.L. Nephrology. Clinical recommendations. Moscow: GEOTAR-Media, 2016. 816 p. (In Russian).
9. Weber B.R, Dieter R.S. Renal artery stenosis: epidemiology and treatment. Int J Nephrol Renovasc Dis. 2014; 7: 169–81. DOI: 10.2147/IJNRD.S40175.
10. Hirsch A.T., Haskal Z.J., Hertzer N.R., et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). J Am Coll Cardiol. 2006; 47(6): 1239–312. DOI: 10.1016/j.jacc.2005.10.009.
11. Shilov E.M., Batyushin M.M., Clinical recommendations for the diagnosis and treatment of renovascular hypertension and ischemic kidney disease. Scientific Society of Nephrologists of Russia. Moscow, 2015. 17 p. (In Russian).
12. Sharafeyev A.Z., Khalirakhmanov A.F., Kharisova E.KH. Difficulties in deciding on renal arterial revascularization. Prakticheskaya meditsina. 2016; 4(96): 187–90 (In Russian).
13. Mishima E., Suzuki T., Takeuchi Y., et al. Renovascular hypertension associated with JAK2 V617F positive myeloproliferative neoplasms treated with angioplasty: 2 cases and literature review. J Clin Hypertens. 2018; 20: 798–804. DOI:10.1111/jch.13257.
14. Parikh S.A., Shishehbor M.H., Gray B.H., et al. SCAI expert consensus statement for renal artery stenting appropriate use. Catheter Cardiovasc Interv. 2014; 84(7): 1163–71. DOI: 10.1002/ccd.25559.
15. Levey A.S., Stevens L.A., Schmid C.H., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9): 604–12. DOI:10.7326/0003-4819-150-9-200905050-00006.
16. Karpov Yu.A. Dual antiplatelet therapy: clinical areas. Russkiy meditsinskiy zhurnal. 2013; 27: 1343. (In Russian).
17. Carobbio A., Thiele J., Passamonti F., et al. Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients. Blood. 2011; 117: 5857–9.
18. Arnar D., Petursson M.K., Jonmundsson E., Bjornsdottir D.J. Renovascular hypertension and coronary heart disease complicating essential thrombocythemia. Eur Heart J. 1993; 14: 576–8.
19. Hasselbalch H.C. Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer? Blood. 2012; 119(14): 3219–25. DOI: 10.1182/blood-2011-11-394775.
20. Cucuianu A., Stoia M., Farcas A., et al. Arterial stenosis and atherothrombotic events in polycythemia vera and essential thrombocythemia. Rom J Intern Med. 2006; 44: 397–406.
Review
For citations:
Popov D.Yu., Kiselev N.S., Stolyar A.G. Endovascular correction of renal artery stenosis of the solitary functioning kidney in a patient with essential thrombocythemia. Russian journal of hematology and transfusiology. 2024;69(2):260-268. (In Russ.) https://doi.org/10.35754/0234-5730-2024-69-2-260-268
Views:
256
Email this article 
